WPI 3 (Paliperidone Extended-Release 3 mg)
Pill with imprint WPI 3 is White, Round and has been identified as Paliperidone extended-release 3 mg. It is supplied by Actavis Pharma, Inc..
Paliperidone is used in the treatment of schizoaffective disorder; schizophrenia; bipolar disorder; autism; borderline personality disorder (and more), and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Paliperidone 3 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3
Paliperidone extended-release
- Imprint:
- WPI 3
- Strength:
- 3 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Atypical antipsychotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-3693
More about paliperidone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 175 Reviews – Add your own review/rating
- Drug class: atypical antipsychotics
Consumer resources
- Paliperidone
- Paliperidone injection
- Paliperidone Extended-Release Tablets
- Paliperidone (Advanced Reading)
- Paliperidone Intramuscular (Advanced Reading)
Other brands: Invega, Invega Sustenna, Invega Trinza
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
